Similar articles

• Efficacy of colistin combination therapy in a mouse model of pneumonia caused by multidrug-resistant Pseudomonas aeruginosa.

  Aoki N, Tateda K, Kikuchi Y, Kimura S, Miyazaki C, Ishii Y, Tanabe Y, Gejyo F, Yamaguchi K. Aoki N, et al. J Antimicrob Chemother. 2009 Mar;63(3):534-42. doi: 10.1093/jac/dkn530. Epub 2009 Jan 14. J Antimicrob Chemother. 2009. PMID: 19147523
• [Pseudomonas pyocyanea infections in otorhinolaryngology].

  Nicoucar GR. Nicoucar GR. Pract Otorhinolaryngol (Basel). 1969;31(6):359-64. Pract Otorhinolaryngol (Basel). 1969. PMID: 4314671 French. No abstract available.
• Pseudomonas aeruginosa contamination of hydrophilic contact lenses and solutions.

  Milauskas AT. Milauskas AT. Trans Am Acad Ophthalmol Otolaryngol. 1972 Mar-Apr;76(2):511-6. Trans Am Acad Ophthalmol Otolaryngol. 1972. PMID: 4200565 No abstract available.
• Current therapies for pseudomonas aeruginosa.

  Giamarellou H, Kanellakopoulou K. Giamarellou H, et al. Crit Care Clin. 2008 Apr;24(2):261-78, viii. doi: 10.1016/j.ccc.2007.12.004. Crit Care Clin. 2008. PMID: 18361945 Review.
• The role of pyocyanin in Pseudomonas aeruginosa infection.

  Lau GW, Hassett DJ, Ran H, Kong F. Lau GW, et al. Trends Mol Med. 2004 Dec;10(12):599-606. doi: 10.1016/j.molmed.2004.10.002. Trends Mol Med. 2004. PMID: 15567330 Review.